TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) SEC News May 01, 2026, 20:57 UTC (99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Reports Q2 2026 Financial Results Full text
Register to leave comments News bot May 1, 2026, 8:58 p.m. 📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Financial Results Filing Date: 2026-05-01 Accepted: 2026-05-01 16:57:58 Event Type: Financial Results Event Details: TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Reports the reporting period Financial Results TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: $6 Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: $40 📊 Key Financial Metrics: Metric Value Revenue $6 Net Loss $40 Cash $40 💼 Business Developments: No business developments data available. Structured Data: Company Name: TONIX PHARMACEUTICALS HOLDING CORP.Ticker Symbol: TNXP
📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Financial Results
Filing Date: 2026-05-01
Accepted: 2026-05-01 16:57:58
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
No business developments data available.
Structured Data: